Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07726238) titled 'A Third Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Kingdom
Condition:
Body Odor
Intervention:
Other: NOBO postbiotic
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 27, 2026
Target Sample Size: 14
Countries of Recruitment:
United States
To know more, visit https://clinic...